Categories AlphaGraphs, Earnings, Health Care

Infographic: Moderna (MRNA) Q2 2023 Earnings Results

Moderna, Inc. (NASDAQ: MRNA) reported second quarter 2023 earnings results today.

Total revenue dropped to $344 million from $4.7 billion in the same period last year, mainly due to a decrease in sales of the company’s COVID-19 vaccine.

Net loss was $1.4 billion, or $3.62 per share, compared to net income of $2.2 billion, or $5.24 per share, last year.  

Product sales were $293 million, down 94% compared to last year, mainly due to lower sales volume. The company reported $0.3 billion in COVID-19 vaccine sales in Q2.

For FY2023, the company is expecting COVID-19 sales of $6-8 billion, dependent on US vaccination rates.

Most Popular

US Bancorp (USB) reports lower adj. earnings for Q2; revenue drops

Financial services company U.S. Bancorp (NYSE: USB) on Wednesday announced operating results for the second quarter of 2024, reporting a decline in revenues and adjusted net income. Total net revenue

Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today. Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales growth was 6.6%. Net income decreased 12.8% to

What to look for when Coca-Cola Company (KO) reports Q2 results

The Coca-Cola Company (NYSE: KO) is all set to unveil its second-quarter 2024 financial results next week. Over the years, it has constantly innovated its portfolio and expanded far beyond

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top